The market potential is clear: Experts predict that 1 in 2 adults will be obese by 2030
Ideal Candidates Adults seeking a high-efficacy brightening and rejuvenation protocol
Do the IV in the shot
Biosimilar entrants not yet approved in major regulated markets are not considered in base year estimates due to regulatory uncertainty
CrossRef BIOTECHNOLOGY AND BIOENGINEERING INNOVATIONS IN PRECISION OBESITY MANAGEMENT: MECHANISTIC INSIGHTS, EMERGING PLATFORMS, AND TRANSLATIONAL PATHWAYS MIN HO HAN, YOUN SEON HWANG, DO HYEON JIN, JIN WOO KIM Journal of Mechanics in Medicine and Biology.2026;[Epub] CrossRef A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass Federica Moscucci, Francesco Baratta, Daniele Pastori, Danilo Menichelli, Anna Vittoria Mattioli, Sabina Gallina, Ilaria Lospinuso, Susanna Sciomer, Gianfranco Piccirillo, Giovambattista Desideri Nutrients.2026